Brief: Highbridge Capital Management, Llc Reports 9% Passive Stake In Fortress Biotech, Inc. As Of Sept 30 - SEC Filing
25/10/2024 15:20
Oct 25 (Reuters) - Fortress Biotech Inc FBIO.O :
* HIGHBRIDGE CAPITAL MANAGEMENT, LLC REPORTS 9% PASSIVE
STAKE IN
FORTRESS BIOTECH, INC. AS OF SEPT 30 - SEC FILING
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortress Biotech
See all newsFortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Fortress Biotech And Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fortress Biotech Q1 net income jumps on PRV sale
Brief: Journey Medical Corporation Secures Contract With Third Major Gpo For Emrosi